Clinical Trial Update: Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease [Phase 1, Phase 2]

View source ↗

Summary

The study evaluated intravenous Ca-DTPA and Zn-DTPA for gadolinium deposition disease in a Phase 1/2 trial conducted by UNC; the trial was terminated and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gadolinium Deposition Disease

Drugs mentioned

• Ca-DTPA (calcium trisodium diethylenetriaminepentaacetate)
• Zn-DTPA (zinc diethylenetriaminepentaacetic acid)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Headache, Cognitive Disturbance | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-04-06